Immune Design Corp. – NASDAQ:IMDZ

Add to watchlist

5.85

Market closed

Open in about 5 hours

+0.34%

month

+350.00%

quarter

+77.27%

year

Market Cap	280.8M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	N/A

Revenue	2.19M
EBITDA	907K
Income	N/A
Revenue Q/Q	-1.85%
Revenue Y/Y	-69.47%

Profit margin	0%
Oper. margin	-2597.91%
Gross margin	34.65%
EBIT margin	-2597.91%
EBITDA margin	41.3%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Profit Margin

Q Y

Immune Design Corp. (NASDAQ:IMDZ): Profit margin
Mar 2018	503K	-13.3M	-2644.14%
Jun 2018	755K	-13.80M	-1828.87%
Sep 2018	462K	-14.04M	-3040.91%
Dec 2018	476K	41.15M	8646.43%

IMDZ income statement history

Debt to Assets

Q Y

Immune Design Corp. (NASDAQ:IMDZ): Debt to assets
Mar 2018	135314000	6.45M	4.77%
Jun 2018	124732000	8.00M	6.42%
Sep 2018	113185000	8.69M	7.68%
Dec 2018	100960000	8.95M	8.87%

IMDZ balance sheet history

Cash Flow

Q Y

Immune Design Corp. (NASDAQ:IMDZ): Cash Flow
Mar 2018	-16.38M	9.87M	226K
Jun 2018	-10.91M	12.04M	131K
Sep 2018	-12.96M	8.07M	0
Dec 2018	-11.39M	20.93M	-129K

IMDZ cash flow history

Immune Design Corp.
Patents

Status	Patent	Filling date	Issue date
Grant	Grant Utility: Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof Filling date: 8 Nov 2016 Issue date: 21 Jun 2022	8 Nov 2016	21 Jun 2022
Application	Application RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS Filling date: 3 Sep 2021 Issue date: 24 Mar 2022	3 Sep 2021	24 Mar 2022
Application	Application RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS Filling date: 3 Sep 2021 Issue date: 24 Feb 2022	3 Sep 2021	24 Feb 2022
Application	Application PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES AND RNA IMMUNOGENIC COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS FOR TREATING CANCER Filling date: 16 Dec 2019 Issue date: 24 Feb 2022	16 Dec 2019	24 Feb 2022
Grant	Grant Utility: Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids Filling date: 9 Nov 2016 Issue date: 5 Oct 2021	9 Nov 2016	5 Oct 2021
Grant	Grant Utility: Materials and methods for producing improved lentiviral vector particles Filling date: 16 Jul 2019 Issue date: 4 May 2021	16 Jul 2019	4 May 2021
Grant	Grant Utility: GLA monotherapy for use in cancer treatment Filling date: 20 May 2019 Issue date: 4 May 2021	20 May 2019	4 May 2021
Application	Application A RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS Filling date: 9 Nov 2016 Issue date: 13 Aug 2020	9 Nov 2016	13 Aug 2020
Grant	Grant Utility: Multigenome retroviral vector preparations and methods and systems for producing and using same Filling date: 6 Dec 2018 Issue date: 10 Mar 2020	6 Dec 2018	10 Mar 2020
Application	Application MATERIALS AND METHODS FOR PRODUCING IMPROVED LENTIVIRAL VECTOR PARTICLES Filling date: 16 Jul 2019 Issue date: 30 Jan 2020	16 Jul 2019	30 Jan 2020

IMDZ patents

Frequently Asked Questions (FAQ)

What's the price of Immune Design Corp. stock today?

One share of Immune Design Corp. stock can currently be purchased for approximately $5.85.
When is Immune Design Corp.'s next earnings date?

Unfortunately, Immune Design Corp.'s (IMDZ) next earnings date is currently unknown.
Does Immune Design Corp. pay dividends?

No, Immune Design Corp. does not pay dividends.
How much money does Immune Design Corp. make?

Immune Design Corp. has a market capitalization of 280.8M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 69.48% to 2.2M US dollars.
What is Immune Design Corp.'s stock symbol?

Immune Design Corp. is traded on the NASDAQ under the ticker symbol "IMDZ".
What is Immune Design Corp.'s primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Immune Design Corp.?

Shares of Immune Design Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
What is Immune Design Corp.'s official website?

The official website for Immune Design Corp. is immunedesign.com.